2invest Past Earnings Performance
Past criteria checks 2/6
2invest's earnings have been declining at an average annual rate of -19%, while the Biotechs industry saw earnings growing at 13.6% annually. Revenues have been growing at an average rate of 70.3% per year. 2invest's return on equity is 8.2%, and it has net margins of 65%.
Key information
-19.0%
Earnings growth rate
-19.0%
EPS growth rate
| Biotechs Industry Growth | -14.6% |
| Revenue growth rate | 70.3% |
| Return on equity | 8.2% |
| Net Margin | 65.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How 2invest makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 8 | 5 | 0 | 0 |
| 31 Mar 24 | 8 | 3 | 0 | 0 |
| 31 Dec 23 | 9 | 2 | 0 | 0 |
| 30 Sep 23 | 6 | -3 | 0 | 0 |
| 30 Jun 23 | 2 | -8 | 0 | 0 |
| 31 Mar 23 | 3 | -15 | 0 | 0 |
| 31 Dec 22 | 3 | -21 | 0 | 0 |
| 30 Sep 22 | 3 | -20 | 0 | 0 |
| 30 Jun 22 | 3 | -20 | 0 | 0 |
| 31 Mar 22 | 2 | -11 | 0 | 0 |
| 31 Dec 21 | 2 | -2 | 0 | 0 |
| 30 Sep 21 | 1 | -12 | -1 | 0 |
| 30 Jun 21 | 1 | -12 | 0 | 0 |
| 31 Mar 21 | 0 | 56 | 0 | 0 |
| 31 Dec 20 | 0 | 55 | 0 | 0 |
| 30 Sep 20 | 0 | 36 | -2 | 0 |
| 30 Jun 20 | 0 | 36 | -1 | 0 |
| 31 Mar 20 | 1 | -4 | 4 | 0 |
| 31 Dec 19 | 0 | -33 | 0 | 0 |
| 30 Sep 19 | -7 | -4 | -1 | 0 |
| 30 Jun 19 | -4 | -3 | 0 | 0 |
| 31 Mar 19 | -1 | -3 | 3 | 0 |
| 31 Dec 18 | 1 | -3 | 4 | 0 |
| 30 Sep 18 | 12 | -2 | 10 | 1 |
| 30 Jun 18 | 10 | -3 | 10 | 1 |
| 31 Mar 18 | 9 | -3 | 9 | 1 |
| 31 Dec 17 | 8 | -4 | 8 | 1 |
| 30 Sep 17 | 6 | -5 | 8 | 1 |
| 30 Jun 17 | 4 | -5 | 6 | 1 |
| 31 Mar 17 | 3 | -5 | 5 | 1 |
| 31 Dec 16 | 2 | -4 | 3 | 1 |
| 30 Sep 16 | 1 | -3 | 3 | 1 |
| 30 Jun 16 | 1 | -4 | 3 | 1 |
| 31 Mar 16 | 1 | -4 | 3 | 1 |
| 31 Dec 15 | 1 | -4 | 3 | 1 |
| 30 Sep 15 | 0 | -4 | 2 | 1 |
| 30 Jun 15 | 0 | -4 | 2 | 1 |
| 31 Mar 15 | 0 | -3 | 2 | 1 |
| 31 Dec 14 | 0 | -3 | 2 | 1 |
| 30 Sep 14 | 0 | -3 | 2 | 2 |
| 30 Jun 14 | 0 | -3 | 2 | 2 |
| 31 Mar 14 | 0 | -3 | 2 | 2 |
| 31 Dec 13 | 0 | -3 | 2 | 2 |
| 30 Sep 13 | 0 | -3 | 2 | 2 |
Quality Earnings: 2INV has a large one-off loss of €5.0M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 2INV became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2INV has become profitable over the past 5 years, growing earnings by -19% per year.
Accelerating Growth: 2INV has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2INV has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (-17.8%).
Return on Equity
High ROE: 2INV's Return on Equity (8.2%) is considered low.